Global Urinary Tract Infection Testing Market

Urinary Tract Infection Testing Market Size, Share, Growth Analysis, By Test Kit (Home Test Kits, Laboratory Test Kits), By Infection Type (Urethritis, Cystitis), By Test Type (Urinalysis, Urine Cultures), By End User, By Region - Industry Forecast 2026-2033

Report ID: SQMIG35D2169 | Region: Global | Published Date: December, 2025
Pages: 219 |Tables: 116 |Figures: 77

To request a free sample copy of this report, please complete the form below.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt

    • FAQs

    Global Urinary Tract Infection Testing Market size was valued at USD 638.27 Million in 2024 and is poised to grow from USD 667.63 Million in 2025 to USD 956.73 Million by 2033, growing at a CAGR of 4.6% during the forecast period (2026–2033). 

    The competitive landscape of the global urinary tract infection (UTI) market is characterized by a diverse array of players vying for market share. Established diagnostics and pharmaceutical companies, as well as innovative startups, contribute to the market's dynamism. These entities focus on developing advanced diagnostic tools, therapeutic solutions, and innovative treatment approaches to address the growing burden of UTIs. The competitive scenario is driven by a continuous quest for improved accuracy, faster results, and patient-friendly testing methods. 'Abbott Laboratories (USA) ', 'Becton, Dickinson and Company (BD) (USA) ', 'bioMérieux SA (France) ', 'Thermo Fisher Scientific Inc. (USA) ', 'Siemens Healthineers AG (Germany) ', 'F. Hoffmann-La Roche Ltd (Switzerland) ', 'Bio-Rad Laboratories, Inc. (USA) ', 'Cepheid (USA) (Parent Company: Danaher Corporation) ', 'Hologic, Inc. (USA) ', 'Quidel Corporation (USA) ', 'Meridian Bioscience, Inc. (USA) ', 'Luminex Corporation (USA) ', 'QIAGEN N.V. (Netherlands) ', 'Beckman Coulter, Inc. (USA) (Parent Company: Danaher Corporation) ', 'Sysmex Corporation (Japan) ', 'OraSure Technologies, Inc. (USA) ', 'GenMark Diagnostics, Inc. (USA) ', 'Mesa Biotech, Inc. (USA) ', 'Alere Inc. (USA) (Parent Company: Abbott Laboratories) ', 'T2 Biosystems, Inc. (USA) '

    The global urinary tract infection (UTI) market is significantly influenced by the escalating prevalence of antibiotic resistant UTIs. The overuse and misuse of antibiotics have led to the emergence of bacteria that are resistant to traditional treatments, complicated UTI management. This pressing concern has driven the need for accurate diagnostic tools such as urine cultures and susceptibility testing, enabling healthcare providers to identify effective treatment options tailored to specific bacterial strains. Additionally, the urgency to contain antibiotic resistance has spurred investments in research and development for novel therapies, further shaping the market's dynamics toward innovative solutions that combat resistant UTIs while promoting prudent antibiotic use.

    Rise of Point-of-Care (POC) Testing: In the global urinary tract infection (UTI) market, a prominent trend is the increasing adoption of Point-of-Care (POC) testing methods. POC tests offer rapid results and convenient on-site diagnostics, eliminating the need for centralized laboratory facilities and reducing turnaround times. This trend aligns with the demand for quick and accurate UTI diagnosis, especially in primary care settings. The integration of POC testing technologies empowers healthcare professionals to make timely treatment decisions, improve patient outcomes, and optimize resource allocation. As technology advancements continue to enhance the accuracy and efficiency of POC tests, their widespread implementation is reshaping the landscape of UTI diagnostics.

    North America emerges as the dominating force in the global urinary tract infection (UTI) market. This is attributed to its well-established healthcare infrastructure, high prevalence of UTIs, and strong emphasis on research and development. Additionally, a heightened awareness about UTIs among the population and swift adoption of advanced diagnostic technologies further fuel market growth.

    Related Reports

    Urinalysis Test Market
    Buy Now GET FREE SAMPLE
    Antimicrobial Susceptibility Testing Market
    Buy Now GET FREE SAMPLE
    Rapid Microbiology Testing Market
    Buy Now GET FREE SAMPLE
    Drug Testing Market
    Buy Now GET FREE SAMPLE
    Kidney Function Test Market
    Buy Now GET FREE SAMPLE
    Urology Devices Market
    Buy Now GET FREE SAMPLE
    Urinary Catheter Market
    Buy Now GET FREE SAMPLE
    Urinary Catheters Market
    Buy Now GET FREE SAMPLE

    Feedback From Our Clients

    Global Urinary Tract Infection Testing Market

    Report ID: SQMIG35D2169

    $5,300
    BUY NOW